Effects of endothelin-1 on norepinephrine-induced vasoconstriction in deoxycorticosterone acetate-salt hypertensive rats

By Kita S.   Taguchi Y.   Chatani S.   Matsumura Y.  

European Journal of Pharmacology, Vol. 344, Iss. 1, 1998-02 ,pp. : 53-57

Elsevier

Access to resources Recommend Favorite

A proteasome inhibitor lessens the increased aortic endothelin-1 content in deoxycorticosterone acetate-salt hypertensive rats

By Okamoto H.   Takaoka M.   Ohkita M.   Itoh M.   Nishioka M.   Matsumura Y.  

European Journal of Pharmacology, Vol. 350, Iss. 1, 1998-05 ,pp. : 11-12

Elsevier

Access to resources Recommend Favorite

5-Carboxamidotryptamine attenuates the development of deoxycorticosterone acetate-salt hypertension in rats

By Balasubramaniam G.   Lee H.S.   Mah S.C.  

European Journal of Pharmacology, Vol. 276, Iss. 1, 1995-03 ,pp. : 183-190

Elsevier

Access to resources Recommend Favorite

Effects of -lipoic acid on deoxycorticosterone acetate-salt-induced hypertension in rats

By Takaoka M.   Kobayashi Y.   Yuba M.   Ohkita M.   Matsumura Y.  

European Journal of Pharmacology, Vol. 424, Iss. 2, 2001-07 ,pp. : 121-129

Elsevier

Access to resources Recommend Favorite

Ebelactone B, an inhibitor of urinary carboxypeptidase Y-like kininase, prevents the development of deoxycorticosterone acetate-salt hypertension in rats

By Majima M.   Ikeda Y.   Kuribayashi Y.   Mizogami S.   Katori M.   Aoyagi T.  

European Journal of Pharmacology, Vol. 284, Iss. 1, 1995-09 ,pp. : 1-11

Elsevier

Access to resources Recommend Favorite